Lexaria Bioscience Corp. (LEXX)
NASDAQ: LEXX · Real-Time Price · USD
2.400
+0.160 (7.14%)
Dec 3, 2024, 10:19 AM EST - Market open

Lexaria Bioscience Stock Forecast

Stock Price Forecast

The 2 analysts with 12-month price forecasts for Lexaria Bioscience stock have an average target of 11, with a low estimate of 10 and a high estimate of 12. The average target predicts an increase of 358.35% from the current stock price of 2.40.

Analyst Consensus: Strong Buy
Target Low Average Median High
Price $10 $11 $12 $12
Change +316.68% +358.35% +400.02% +400.02%

Analyst Ratings

The average analyst rating for LEXX stock from 2 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Rating Jul '24Aug '24Sep '24Oct '24Nov '24Dec '24
Strong Buy 222222
Buy 000000
Hold 000000
Sell 000000
Strong Sell 000000
Total 222222

Latest Forecasts

Analyst Firm Rating Rating Action Price Target Upside Date
HC Wainwright & Co.
HC Wainwright & Co.
Strong Buy
Reiterates
$10
Strong Buy Reiterates $10 +316.68% Dec 2, 2024
HC Wainwright & Co.
HC Wainwright & Co.
Strong Buy
Reiterates
$10
Strong Buy Reiterates $10 +316.68% Nov 25, 2024
HC Wainwright & Co.
HC Wainwright & Co.
Strong Buy
Reiterates
$10
Strong Buy Reiterates $10 +316.68% Jul 18, 2024
HC Wainwright & Co.
HC Wainwright & Co.
Strong Buy
Initiates
$10
Strong Buy Initiates $10 +316.68% Jul 10, 2024
Maxim Group
Maxim Group
Strong Buy
Maintains
$3$12
Strong Buy Maintains $3$12 +400.02% Mar 5, 2024
More Analyst Ratings

Financial Forecast

Revenue This Year
411.74K
from 226.21K
Increased by 82.02%
Revenue Next Year
803.25K
from 411.74K
Increased by 95.09%
EPS This Year
-0.64
from -1.01
EPS Next Year
-0.40
from -0.64
Fiscal Year FY 2019 FY 2020 FY 2021 FY 2022 FY 2023 FY 2024 FY 2025 FY 2026
Period Ending Aug 31, 2019 Aug 31, 2020 Aug 31, 2021 Aug 31, 2022 Aug 31, 2023 Aug 31, 2024 Aug 31, 2025 Aug 31, 2026
Revenue
222.61K314.79K722.74K255.40K226.21K411.74K803.25K1.19M
Revenue Growth
-48.62%41.41%129.59%-64.66%-11.43%82.02%95.09%48.40%
EPS
-1.58-1.42-0.92-1.24-1.01-0.64-0.40-0.48
EPS Growth
--------
Forward PE
--------
No. Analysts -----554
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue 202420252026202720282029
High 556,500 1.0M 1.2M
Avg 411,743 803,250 1.2M
Low 147,980 588,000 1.1M

Revenue Growth

Revenue Growth 202420252026202720282029
High
146.0%
148.7%
52.8%
Avg
82.0%
95.1%
48.4%
Low
-34.6%
42.8%
42.7%

EPS Forecast

EPS 202420252026
High -0.42 -0.35 -0.36
Avg -0.64 -0.40 -0.48
Low -0.99 -0.47 -0.59

EPS Growth

EPS Growth 202420252026
High - - -
Avg - - -
Low - - -
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.